Tech Company Financing Transactions
Chimerix Funding Round
Chimerix closed a $45 million Series F funding round on 2/11/2011. Backers included private investors.
Transaction Overview
Company Name
Announced On
2/11/2011
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series F
Investors
Proceeds Purpose
Funding will be used as the company continues to push an antiviral drug through FDA approval procedures.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2505 Meridian Pkwy. 100
Durham, NC 27713
USA
Durham, NC 27713
USA
Phone
Website
Email Address
Overview
Incorporated in 2000, Chimerix is a biopharmaceutical company committed to the discovery, development, and commercialization of novel oral antiviral therapeutics that are designed to transform patient care in areas of high unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Sherman
Chief Medical Officer
Garrett Nichols
Chief Scientific Officer
Randall Lanier
VP - Client Services
Odin Naderer
VP - General Counsel
Michael Alrutz
VP - Manufacturing
Roy Ware
Browse more venture capital transactions:
Prev: 2/11/2011: Damballa venture capital transaction
Next: 2/11/2011: One Kings Lane venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs